Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

Tue, 16th Apr 2024 09:48

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

----------

FTSE 100

----------

Deutsche Bank raises AstraZeneca to 'hold' (sell) - price target 10,500 (9,500) pence

----------

Barclays raises AstraZeneca price target to 13,000 (12,500) pence - 'overweight'

----------

Deutsche Bank raises Flutter target to 17,589 (17,154) pence - 'buy'

----------

Citigroup raises Sage Group price target to 1,350 (1,300) pence - 'buy'

----------

Barclays raises Rio Tinto price target to 6,000 (5,900) pence - 'overweight'

----------

Barclays raises Glencore price target to 515 (435) pence - 'equal weight'

----------

Barclays raises Fresnillo price target to 630 (480) pence - 'equal weight'

----------

Barclays raises Antofagasta price target to 1,725 (1,295) pence - 'underweight'

----------

Barclays raises Anglo American price target to 2,715 (2,500) pence - 'overweight'

----------

Barclays cuts Phoenix Group to 'underweight' (overweight) - price target 500 (600) pence

----------

RBC raises Admiral Group to 'outperform' (sector perform) - price target 3,400 (2,600) pence

----------

Jefferies raises Smurfit Kappa price target to 4,100 (3,750) pence - 'buy'

----------

FTSE 250

----------

HSBC raises Savills to 'buy' (hold) - price target 1,260 (825) pence

----------

Peel Hunt raises Moneysupermarket.com to 'buy' (add) - price target 280 pence

----------

Goldman Sachs cuts Dr Martens price target to 71.30 (87) pence - 'sell'

----------

JPMorgan cuts Oxford Instruments target to 2,400 (2,500) pence - 'overweight'

----------

JPMorgan cuts Auction Technology group target to 570 (582) pence - 'neutral'

----------

Barclays raises Hochschild Mining target to 170 (125) pence - 'overweight'

----------

Barclays raises Endeavour Mining target to 3,200 (2,600) pence - 'overweight'

----------

Barclays cuts Ferrexpo price target to 100 (120) pence - 'equal weight'

----------

Berenberg cuts Kainos price target to 1,260 (1,315) pence - 'buy'

----------

SMALL CAP AND OTHER MAIN MARKET

----------

Deutsche Bank raises Alphawave price target to 200 (180) pence - 'buy'

----------

Goldman Sachs cuts Learning Technologies group target to 93 (97) pence - 'neutral'

----------

Barclays raises South32 price target to 220 (193) pence - 'overweight'

----------

Barclays cuts Petra Diamonds price target to 42 (55) pence - 'equal weight'

----------

Barclays raises BHP price target to 2,700 (2,520) pence - 'equal weight'

----------

Berenberg cuts Ceres Power price target to 650 (800) pence - 'buy'

----------

Goldman Sachs cuts Ceres Power price target to 230 (270) pence - 'buy'

----------

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

Related Shares

More News
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negoti...

29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while a...

29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe a...

29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.